Literature DB >> 25061176

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

Siobhan V Glavey1, Salomon Manier2, Alessandro Natoni3, Antonio Sacco2, Michele Moschetta2, Michaela R Reagan2, Laura S Murillo3, Ilyas Sahin2, Ping Wu4, Yuji Mishima2, Yu Zhang2, Wenjing Zhang2, Yong Zhang2, Gareth Morgan4, Lokesh Joshi5, Aldo M Roccaro2, Irene M Ghobrial2, Michael E O'Dwyer6.   

Abstract

Glycosylation is a stepwise procedure of covalent attachment of oligosaccharide chains to proteins or lipids, and alterations in this process, especially increased sialylation, have been associated with malignant transformation and metastasis. The role of altered sialylation in multiple myeloma (MM) cell trafficking has not been previously investigated. In the present study we identified high expression of β-galactoside α-2,3-sialyltransferase, ST3GAL6, in MM cell lines and patients. This gene plays a key role in selectin ligand synthesis in humans through the generation of functional sialyl Lewis X. In MRC IX patients, high expression of this gene is associated with inferior overall survival. In this study we demonstrate that knockdown of ST3GAL6 results in a significant reduction in levels of α-2,3-linked sialic acid on the surface of MM cells with an associated significant reduction in adhesion to MM bone marrow stromal cells and fibronectin along with reduced transendothelial migration in vitro. In support of our in vitro findings, we demonstrate significantly reduced homing and engraftment of ST3GAL6 knockdown MM cells to the bone marrow niche in vivo, along with decreased tumor burden and prolonged survival. This study points to the importance of altered glycosylation, particularly sialylation, in MM cell adhesion and migration.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25061176      PMCID: PMC4162107          DOI: 10.1182/blood-2014-03-560862

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

Authors:  Yazan Alsayed; Hai Ngo; Judith Runnels; Xavier Leleu; Ujjal K Singha; Costas M Pitsillides; Joel A Spencer; Teresa Kimlinger; Joanna M Ghobrial; Xiaoying Jia; Ganwei Lu; Michael Timm; Ashok Kumar; Daniel Côté; Israel Veilleux; Karen E Hedin; G David Roodman; Thomas E Witzig; Andrew L Kung; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

2.  Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.

Authors:  Aldo Maria Roccaro; Teru Hideshima; Noopur Raje; Shaji Kumar; Kenji Ishitsuka; Hiroshi Yasui; Norihiko Shiraishi; Domenico Ribatti; Beatrice Nico; Angelo Vacca; Franco Dammacco; Paul Gerard Richardson; Kenneth Carl Anderson
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 3.  Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes.

Authors:  Christopher P Dillon; Peter Sandy; Alessio Nencioni; Stephan Kissler; Douglas A Rubinson; Luk Van Parijs
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

4.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.

Authors:  Dorothy A Sipkins; Xunbin Wei; Juwell W Wu; Judith M Runnels; Daniel Côté; Terry K Means; Andrew D Luster; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

5.  Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.

Authors:  Wee J Chng; Shaji Kumar; Scott Vanwier; Greg Ahmann; Tammy Price-Troska; Kim Henderson; Tae-Hoon Chung; Seungchan Kim; George Mulligan; Barbara Bryant; John Carpten; Morie Gertz; S Vincent Rajkumar; Martha Lacy; Angela Dispenzieri; Robert Kyle; Philip Greipp; P Leif Bergsagel; Rafael Fonseca
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells.

Authors:  P P Wilkins; R P McEver; R D Cummings
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

8.  Roles for UDP-GlcNAc 2-epimerase/ManNAc 6-kinase outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM3 and GD3 biosynthesis, proliferation, and apoptosis, and ERK1/2 phosphorylation.

Authors:  Zhiyun Wang; Zhonghui Sun; Adrienne V Li; Kevin J Yarema
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

9.  The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Xiaoying Jia; Judith Runnels; Hai T Ngo; Anne-Sophie Moreau; Mena Farag; Joel A Spencer; Costas M Pitsillides; Evdoxia Hatjiharissi; Aldo Roccaro; Garrett O'Sullivan; Douglas W McMillin; Daisy Moreno; Tanyel Kiziltepe; Ruben Carrasco; Steven P Treon; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-08-30       Impact factor: 22.113

10.  Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin.

Authors:  P P Wilkins; K L Moore; R P McEver; R D Cummings
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

View more
  55 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy.

Authors:  Dongjun Lee; Ying-Hua Wang; Demetrios Kalaitzidis; Janani Ramachandran; Homare Eda; David B Sykes; Noopur Raje; David T Scadden
Journal:  J Clin Invest       Date:  2016-02-29       Impact factor: 14.808

Review 3.  New therapeutic targets for cancer bone metastasis.

Authors:  Jing Y Krzeszinski; Yihong Wan
Journal:  Trends Pharmacol Sci       Date:  2015-05-09       Impact factor: 14.819

4.  DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.

Authors:  Duncan R Hewett; Kate Vandyke; David M Lawrence; Natasha Friend; Jacqueline E Noll; Joel M Geoghegan; Peter I Croucher; Andrew C W Zannettino
Journal:  Neoplasia       Date:  2017-11-05       Impact factor: 5.715

5.  3d Tissue Engineered In Vitro Models Of Cancer In Bone.

Authors:  Anna M Sitarski; Heather Fairfield; Carolyne Falank; Michaela R Reagan
Journal:  ACS Biomater Sci Eng       Date:  2017-06-09

6.  Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-β1 Production.

Authors:  Yin Wu; Chao Lan; Dongren Ren; Guo-Yun Chen
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

7.  Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma.

Authors:  Gabriel M Pagnotti; M Ete Chan; Benjamin J Adler; Kenneth R Shroyer; Janet Rubin; Steven D Bain; Clinton T Rubin
Journal:  Bone       Date:  2016-06-02       Impact factor: 4.398

Review 8.  Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.

Authors:  Michele Moschetta; Yawara Kawano; Antonio Sacco; Angelo Belotti; Rossella Ribolla; Marco Chiarini; Viviana Giustini; Diego Bertoli; Alessandra Sottini; Monica Valotti; Claudia Ghidini; Federico Serana; Michele Malagola; Luisa Imberti; Domenico Russo; Alessandro Montanelli; Giuseppe Rossi; Michaela R Reagan; Patricia Maiso; Bruno Paiva; Irene M Ghobrial; Aldo M Roccaro
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 9.  Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.

Authors:  Michaela R Reagan; Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2015-11-26       Impact factor: 20.543

Review 10.  Multiple myeloma in the marrow: pathogenesis and treatments.

Authors:  Heather Fairfield; Carolyne Falank; Lindsey Avery; Michaela R Reagan
Journal:  Ann N Y Acad Sci       Date:  2016-01       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.